Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
My Lists

Vicuron Pharmaceuticals  (Stock symbol: MICU ) Acquired by Pfizer (2005 $ 1,900,000,000)

34790 Ardentech Court
Fremont, CA 94555
Website Company Summary Management Team

President/COO/Operations: Claudia Quarta (2003)
Finance: Dov A. Goldstein
Technology: Richard J. White
Sales/Marketing: Lyn Wiesinger

Outside board: (May no longer be on the board) James H. Cavanaugh (Healthcare Ventures);  Ubaldo Livolsi (Livolsi & Partners S.p.a.);  David Milligan (Abbott Laboratories)
Former outside board: Timothy J. Barberich (Sepracor);  Tim Henkel (SmithKline Beecham);  Mark Leschly (RHO Capital Partners) Tom McConnell (NEA);  Lori F. Rafield (Patricof & Co. Ventures) Christopher T. Walsh (Hamilton Kuhn Professor)

Business description: Vicuron Pharmaceuticals is a biopharmaceutical company committed to discovering, developing and commercializing novel antifungal and antibiotic agents with distinct competitive advantages. Its lead products, anidulafungin, a novel antifungal agent, and dalbavancin, a novel antibiotic for the treatment of serious Gram-positive infections, are in the advanced stages of clinical development. The company's versatile research engine integrates industry-leading expertise in functional genomics, automated screening and combinatorial and medicinal chemistry. In addition, Vicuron Pharmaceuticals has extensive research and development collaborations with leading pharmaceutical and anti-infective development companies, such as Pharmacia Corporation, Novartis and Biosearch Italia.
Partners include: Novartis;  Biosearch Italia;  Pharmacia

Rounds: 2
Capital raised: 73.0M
Ownership: Acquired by Pfizer (2005 $ 1,900,000,000)
Stock Symbol: MICU
Angels/other VCs: Tim Barbarich (Sepraco)
Corporate investors: SmithKline

Last Tweets


Last Mentions

Record updated: Nov 2005
Sector: Biotech
Year Founded: 1996
Headcount: 51-75 as of Dec 2002
Rounds: 2
Capital Raised: 73.0M
Ownership: Acquired by Pfizer (2005 $ 1,900,000,000)
Stock Symbol: MICU